Bionoid Pharma, Inc.
Built from real-time financials, refreshed daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a BINP research report →
Price Chart
About the company
Bionoid Pharma, Inc. functions as a medical technology enterprise. This company concentrates on the creation and commercialization of advanced medical instruments and solutions, primarily targeting the orthopedic and pain management industries.
- CEO
- Patricia Colvin
- IPO
- 2007
- Employees
- 5
- HQ
- Beverly Hills, CA, US
Get TickerSpark's AI analysis on BINP
Create an account to generate AI analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →Already have an account? Log in
Similar companies
Peers in the same neighborhood.
- Market Cap
- $1.62M
- P/E
- -10.49
- PEG
- 0.11
- P/S
- 0.00
- P/B
- 2.61
- EV/EBITDA
- -46.09
- Div Yield
- 0.00%
- Gross Margin
- 0.00%
- Op Margin
- 0.00%
- Net Margin
- 0.00%
- ROE
- -23.49%
- ROIC
- -24.68%
Latest fiscal year · YoY change
- Revenue
- $0-100.0%
- Gross Profit
- $-276,571-3385.9%
- Op Income
- $-276,571
- Net Income
- $-317,000-2803.6%
- EPS
- $-0.01+0.0%
- OCF Growth
- +0.0%
- FCF Growth
- +0.0%
- 52W High
- $0.45
- 52W Low
- $0.02
- 50D MA
- $0.03
- 200D MA
- $0.08
- Beta
- -4.66
- RSI (14)
- 51
- Avg Volume
- 41.59K
No earnings-call transcripts are available for BINP yet.
- Free Float
- 37.2%
- Shares Outstanding
- 53.99M
- Float Shares
- 20.07M
Our BINP coverage
Recent articles, reports, and earnings notes.
No research on BINP yet
For a full analyst-grade research report — grades, price targets, financials, chart analysis — generate one on demand.
Generate BINP report →AI Maverick Intel Provides Corporate Update
accessnewswire.com · Aug 12
IBN Initiates Coverage of AI Maverick Intel Inc.
accessnewswire.com · Jul 30
AI Maverick Launches Enhanced Prospecting Platform to Deliver Human Like Outreach - No SDR Team Required
accessnewswire.com · Jul 17
Bionoid Pharma, Inc. Confirms Name Change to AI Maverick Intel, Inc. Following Delaware Approval
accessnewswire.com · May 29
Bionoid Pharma, Inc. Rebrands as AI Maverick Intel, Inc. to Reflect Strategic Shift Toward AI-Driven Innovation
accessnewswire.com · May 16
Bionoid Pharma Inc. Announces Completion of 2024 Financial Audit
accessnewswire.com · Apr 11
Bionoid Pharma Inc. Engages Aloba, Awomolo & Partners as External Auditor for 2024 Financial Statements
accessnewswire.com · Apr 9
Bionoid Pharma Announces Filing of OTCQB Application to Enhance Market Visibility and Liquidity
accessnewswire.com · Mar 19
Headlines from third-party outlets — TickerSpark isn't affiliated with these sources.